Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
INCOR is a diversified Indian conglomerate with a significant presence in the healthcare and life sciences sectors. Headquartered in Hyderabad, the company operates a chain of multi-specialty hospitals under the OMNI Hospitals brand and has expanded into the pharmaceutical industry through its subsidiaries, INCOR Renovis Pharma and Incor Lifesciences. INCOR Renovis, a joint venture with Renovis Labs, focuses on developing cost-effective and "green" manufacturing technologies for Active Pharmaceutical Ingredients (APIs) and intermediates using directed evolution and microbiology platforms. The group is committed to making India self-reliant in medicine manufacturing while reducing the environmental impact of pharmaceutical production through automation and innovative chemical-biological solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InCor.